<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01941342</url>
  </required_header>
  <id_info>
    <org_study_id>NDR-2014-02</org_study_id>
    <nct_id>NCT01941342</nct_id>
  </id_info>
  <brief_title>Evaluation of Preoperative Biliary Drainage Before Pancreatoduodenectomy</brief_title>
  <official_title>Evaluation of Preoperative Biliary Drainage on Outcome of Pancreatoduodenectomy: A Multicenter Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southwest Hospital, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southwest Hospital, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of preoperative biliary drainage (PBD)
      which is performed prior to pancreatoduodenectomy candidates with obstructive jaundice by
      observing the prevalence of drainage and surgery related complications, hospital stay,
      medical cost and life quality compared to surgery alone. It is anticipated that PBD can
      reduce the prevalence of complications and improve the outcome of pancreatoduodenectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obstructive jaundice is a common symptom in patients with pancreatic head cancer or
      peri-ampullary cancer. It is regarded that proper surgical resection is the only possible way
      of radical cure for those patients without evidence of metastasis. Since high preoperative
      bilirubin level is suggested to be a risk factor for pancreatoduodenectomy, preoperative
      biliary drainage has been applied to clinical practice to improve the outcome of surgery.
      However, results from previous studies have inconsistent results showing that PBD may have
      adverse effect on patients by elevating the prevalence of complications. Since PBD is widely
      performed worldwide, its value needs to be clarified. Thus the present study is designed to
      systematically evaluate the value of PBD via recruiting participants who may most likely
      benefit from PBD. It is anticipated that results from this study can present an instructive
      conclusion on whether PBD should be performed prior to pancreatoduodenectomy as well as
      reveal the preferable type of PBD.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Infectious Complications</measure>
    <time_frame>up to 12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of Hemorrhagic Complications</measure>
    <time_frame>up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver Function Evaluation</measure>
    <time_frame>up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Bile Leakage</measure>
    <time_frame>up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Pancreatic Leakage</measure>
    <time_frame>up to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Life Quality Score</measure>
    <time_frame>up to 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Digestive Function Recovery</measure>
    <time_frame>up to 6 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Incidence of Incision Complications</measure>
    <time_frame>up to 3 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of Pulmonary Infections</measure>
    <time_frame>up to 6 months</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of Pleural Effusion</measure>
    <time_frame>up to 6 months</time_frame>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">274</enrollment>
  <condition>Pancreatic Cancer</condition>
  <condition>Periampullary Carcinoma</condition>
  <arm_group>
    <arm_group_label>Pancreatoduodenectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Instant pancreatoduodenectomy within one week after diagnosis including: Evaluate the resectability; Remove pancreas head, gastric pyloric antrum, duodenum, distal common bile duct and regional lymph nodes; Reconstruct digestive tract.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ENBD and Pancreatoduodenectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consistent ENBD (Endoscopic Nasobiliary Drainage) for 3 weeks or drainage until bilirubin level decreases to 200μmol per liter or below then perform pancreatoduodenectomy including:
Evaluate the resectability; Remove pancreas head, gastric pyloric antrum, duodenum, distal common bile duct and regional lymph nodes; Reconstruct digestive tract.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EBD and Pancreatoduodenectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consistent EBD (Endoscopic Biliary Drainage) for 3 weeks or drainage until bilirubin level decreases to 200μmol per liter or below then perform pancreatoduodenectomy including:
Evaluate the resectability; Remove pancreas head, gastric pyloric antrum, duodenum, distal common bile duct and regional lymph nodes; Reconstruct digestive tract.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PTCD and Pancreatoduodenectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consistent PTCD (Percutaneous Transhepatic Cholangial Drainage) for 3 weeks or drainage until bilirubin level decreases to 200μmol per liter or below then perform pancreatoduodenectomy including:
Evaluate the resectability; Remove pancreas head, gastric pyloric antrum, duodenum, distal common bile duct and regional lymph nodes; Reconstruct digestive tract.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pancreatoduodenectomy</intervention_name>
    <arm_group_label>Pancreatoduodenectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ENBD and Pancreatoduodenectomy</intervention_name>
    <arm_group_label>ENBD and Pancreatoduodenectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EBD and Pancreatoduodenectomy</intervention_name>
    <arm_group_label>EBD and Pancreatoduodenectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PTCD and Pancreatoduodenectomy</intervention_name>
    <arm_group_label>PTCD and Pancreatoduodenectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 to 70 years old

          -  CT (Computed Tomography), CTA (Computed Tomographic Angiography), MRI (Magnetic
             Resonance Imaging) or ultrasonic test suggested pancreatic head carcinoma or
             periampullary carcinoma with obstructive jaundice

          -  First routine test of serum bilirubin above 250μmol per liter

        Exclusion Criteria:

          -  Distant metastasis in liver, lung or other sites

          -  Invasion of local blood vessels (e.g. aorta, portal vein, postcava)

          -  Poor physical condition, unable to tolerate anesthesia and surgery (e.g. severe
             cardio-pulmonary diseases, blood coagulation disorders)

          -  With cholangitis, active hepatitis or other diseases which should be excluded from
             study according to the investigators
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Huai-zhi Wang, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southwest Hospital, China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Huai-zhi Wang, M.D., Ph.D.</last_name>
    <phone>86-23-13996950719</phone>
    <email>whuaizhi@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institution of Hepatobiliary Surgery, Southwest Hospital</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400038</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Liang-yu Yin, M.D.</last_name>
      <phone>86-23-13937975651</phone>
      <email>liangyuyin1988@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Huai-zhi Wang, M.D., Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 10, 2013</study_first_submitted>
  <study_first_submitted_qc>September 10, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2013</study_first_posted>
  <last_update_submitted>January 13, 2014</last_update_submitted>
  <last_update_submitted_qc>January 13, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southwest Hospital, China</investigator_affiliation>
    <investigator_full_name>Huai-zhi Wang</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>Obstructive Jaundice</keyword>
  <keyword>Preoperative Biliary Drainage</keyword>
  <keyword>Pancreatoduodenectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

